Drug Profile
Bivalent malaria vaccine - Novavax/CPL Biologicals/ICGEB
Alternative Names: Falciparum malaria vaccine - Novavax/CPL Biologicals; JAIVAC-2; Malaria VLP vaccine - Novavax/CPL Biologicals; PfMSPFu24 +PfF2/ AlhydrogelLatest Information Update: 28 Apr 2023
Price :
$50
*
At a glance
- Originator CPL Biologicals; International Centre for Genetic Engineering and Biotechnology; Novavax
- Class Parasitic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Falciparum malaria
Most Recent Events
- 28 Apr 2023 No recent reports of development identified for phase-I development in Falciparum-malaria(Prevention) in India (IM)
- 17 Oct 2022 International Centre for Genetic Engineering and Biotechnology terminates a phase I trial in Falciparum malaria (Prevention) in India (IM) (CTRI/2020/03/023739)
- 06 Mar 2020 Phase-I clinical trials in Falciparum malaria (Prevention) in India (IM) (CTRI/2020/03/023739)